InBody Co (XKRX:041830) Cash-to-Debt : 16.28 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is InBody Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. InBody Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 16.28.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, InBody Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for InBody Co's Cash-to-Debt or its related term are showing as below:

XKRX:041830' s Cash-to-Debt Range Over the Past 10 Years
Min: 8.45 Med: 5009.24 Max: No Debt
Current: 16.28

During the past 13 years, InBody Co's highest Cash to Debt Ratio was No Debt. The lowest was 8.45. And the median was 5009.24.

XKRX:041830's Cash-to-Debt is ranked better than
76.74% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 1.875 vs XKRX:041830: 16.28

InBody Co Cash-to-Debt Historical Data

The historical data trend for InBody Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

InBody Co Cash-to-Debt Chart

InBody Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

8.45

11.99

18.48

13.53

16.28

InBody Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															13.53	15.18	15.93	13.40	16.28

Competitive Comparison of InBody Co's Cash-to-Debt

For the Medical Devices subindustry, InBody Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InBody Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InBody Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where InBody Co's Cash-to-Debt falls into.

InBody Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

InBody Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	98967.403	/	(2444.123	+	3636.17)
	=	16.28

InBody Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	98967.403	/	(2444.123	+	3636.17)
	=	16.28

InBody Co (XKRX:041830) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

InBody Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of InBody Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

InBody Co (XKRX:041830) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InBody Co Ltd (XKRX:041830) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

54, Nonhyeon-ro 2-gil, Gangnam-gu, Seoul, KOR, 135-960

Website

http://www.inbody.com

InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.

InBody Co (XKRX:041830) Headlines

No Headlines